✉news HealthHealth first seen 22 h ago, last 18 h ago, peak #6
GLP-1 lawsuits allege serious harm, but risk remains unclear
Original: Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
Hundreds of lawsuits are underway against makers of GLP-1 weight-loss and diabetes drugs such as Ozempic and Wegovy, alleging the medications caused serious harm, including severe gastrointestinal injuries. Lawyers and patients cite cases of hospitalisation and lasting damage. However, there is no reliable data showing how often such injuries occur among the millions of people taking the drugs, leaving the true risk unknown and the litigation closely watched.
Why now: The suits are moving through US courts against widely used blockbuster drugs, raising unresolved questions about their safety.
OzempicWegovyNovo NordiskEli Lilly
Rank over time, top of the chart is #1. 4 snapshots from 22 h ago to 18 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1743435